DoW Peer Reviewed Medical, Clinical Trial Award
This grant funds clinical trials addressing FY26 congressionally directed medical research topics, offering up to $20M for trials at various phases, with optional planning support and a total budget of $94.5M for about 9 awards.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 23, 2026: Pre-Application (Preproposal) | September 22, 2026: Full Application | September 30, 2026: End of Application Verification Period
Funding Amounts: ~$94.5M total; up to $800,000 (planning phase), $6M (Level 1), $10M (Level 2), $20M (Level 3) per award; max 4 years + 12 months planning
Summary: Supports rapid implementation of clinical trials addressing congressionally directed medical topic areas relevant to military health.
Key Information: Animal/preclinical studies not supported; must address a FY26 PRMRP topic area and strategic goal.
Description
This opportunity funds clinical trials that have the potential to significantly impact the treatment or management of diseases and conditions relevant to military health, as specified in the FY26 Peer Reviewed Medical Research Program (PRMRP) topic areas and strategic goals. The mechanism supports both trials ready to launch and those requiring a final planning/regulatory phase. Projects must be human clinical trials (not preclinical or animal studies) and demonstrate clear relevance to the health needs of military Service Members, Veterans, and their Families.
